ARENA PHARMACEUTICALS, INC. ARNA Cash Flow

Arena pharmaceuticals, inc. (ARNA)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating Activities:
Net income (loss)
-100,207	-88,311	-72,865	-61,403	620,134	68,711	-34,314	-31,833	-31,963	-13,955	-32,664	-23,616	-22,497	38,314	-12,479	-27,183	-21,548	-30,459	-26,418	-26,807	-24,295	-32,061	-10,672	7,480	-25,255	-23,459	-17,200	40,100	-18,876	-21,280	-15,521	-22,099	-26,577	-23,682	-22,736	-22,908	-39,898
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
(Income) loss from discontinued operations
-	-	-	-	-	0	0	0	-830	315	2,606	147	54	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
950	884	794	791	764	896	961	953	949	1,044	1,044	1,080	1,110	-2,011	2,296	2,353	2,356	-1,971	2,452	2,524	2,425	2,221	2,233	2,209	1,992	1,970	1,886	1,927	1,950	1,995	2,336	2,319	2,405	2,433	2,558	2,576	2,560
Deferred income taxes
-	0	0	0	110,333	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangibles
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	37	67	-	57	63	27	112	105	108	181	164	111	95	99	174	168	173	176	178	197	186	436
Share-based compensation
15,214	13,250	13,345	13,428	13,024	5,814	5,166	4,530	4,033	2,097	1,877	2,110	1,771	1,814	2,181	4,271	2,809	2,317	3,848	4,114	3,833	3,568	3,398	3,342	3,201	2,482	2,319	2,438	1,785	1,359	1,352	954	1,407	802	792	824	1,330
Gain from valuation of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	852	1,171	-1,549	929	2,593	1,006	-110	49	4,100	2,142	3,859	461	5,259	-16,770	-2,375	-340	-233	181	439
Amortization of prepaid financing costs
22	23	22	23	22	27	28	27	28	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	34	139	85	54	51	50	283
Amortization of original issue discounts, net of premiums, on available-for-sale investments
264	628	1,572	2,281	1,147	793	-291	-10	172	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-4,668	-1,670	0	0	0	-10,514
Loss (gain) on disposal of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-472	-959	26	135	0	-1,007	0	0	0	-219	2	45	-70	27	-6	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
-1,498	-42	-128	-1,259	-2,003	3,760	-835	496	-661	864	323	271	-12,245	-876	14,787	-2,732	1,067	-665	-528	-8,200	8,612	872	-4,092	5,747	-8,934	-1,857	10,734	-391	-4,013	4,822	-19,469	19,554	353	-1,349	150	-1,155	-524
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	388	428	-973	-	-433	-1,004	197	-659	118	574	-903	2,545	2,295	-75	1,300	3,098	2,777	0	0	-	-	-	-
Prepaid expenses and other assets
9,818	-2,638	-1,670	4,272	8,169	-73	2,367	1,248	-613	-1,830	324	299	622	-2,930	-206	-392	1,112	275	1,134	-511	-257	-1,779	1,436	-1,691	2,806	102	227	-597	333	-978	1,562	192	748	-470	203	-357	85
Payables and accrued liabilities
-1,116	7,142	6,387	-2,262	1,080	8,856	1,666	3,787	-3,438	4,370	3,056	-2,419	-3,204	-6,410	3,304	6,482	-966	19,179	-377	-14,183	-6,711	9,820	7,990	-2,957	-1,613	1,749	16,245	2,388	-810	604	2,170	139	-2,637	5	782	-1,520	-384
Deferred revenues
-	-	-	-	-	-1,215	-200	-200	-446	-1,194	-1,017	-1,084	-1,106	-64,149	-723	-5,192	986	-9,153	-5,861	1,723	8,644	-6,766	-12,961	-5,251	-4,786	63,315	15,754	-2,235	-954	15,481	-863	4,053	-822	-519	-974	-974	-928
Deferred rent
-324	-	-325	-395	-394	-	-328	-277	-274	-	-	-	-	-	-	-	24	-	-	-	29	29	28	31	34	34	33	31	27	27	-69	-16	-45	-48	-49	-48	-42
Other long-term liabilities
-	-	-	-	-	-	-	-	-	-274	-275	-16	-12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) operating activities - continuing operations
-	-	-	-	-	-33,723	-30,755	-38,222	-29,179	-7,227	-19,209	-25,021	-12,335	-17,827	-19,700	-16,187	-17,579	-	-	-	-	-	-	-	-19,116	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities - discontinued operations
-	-	-	-	-	37	-268	499	-601	1,079	900	-907	-3,922	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) operating activities
-94,045	-61,428	-52,416	-55,112	737,650	-33,686	-31,023	-37,723	-29,780	-6,148	-18,309	-25,928	-16,257	-	-	-	-	-	-	-	-23,017	-	-	-	-	-	-	-	-18,224	-	-523	-12,235	-22,250	-15,722	-18,546	-19,585	-24,404
Investing Activities:
Purchases of available-for-sale investments
182,794	220,576	338,913	660,206	249,525	338,960	102	0	25,477	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale and maturity of available-for-sale investments
222,235	356,652	359,657	183,696	76,088	25,531	38,133	21,895	25,005	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
532	1,886	999	839	1,095	124	40	203	325	87	1	12	13	170	267	130	247	-9,681	9,031	700	1,069	2,461	2,025	1,950	2,469	4,564	1,450	1,884	1,266	742	399	362	274	272	95	162	90
Proceeds from sale of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	168	625	26	135	0	2,232	0	0	0	0	2	45	0	28	32	0	-	-	-	-	-	-	-	-
Other non-current assets
-	-	-	-	-	12	1	-4	2	0	-1	4	2	-	-	-	-	-	-	-	-	0	0	0	-209	28	-210	-309	52	105	357	13	-50	108	0	-19	-3
Net cash used in investing activities - continuing operations
-	-	-	-	-	-313,565	37,990	21,696	-799	-113,108	789	-16	-15	3	-301	-104	-112	-	-	-	-	-	-	-	-2,215	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities - discontinued operations
-	-	-	-	-	0	0	415	2,990	-71	0	-29	60	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
38,909	134,190	19,745	-476,352	-174,532	-313,565	37,990	22,111	2,191	-	-	-	45	-	-	-	-	-	-	-	-1,069	-	-	-	-	-	-	-	-1,318	-	-755	-375	-224	-357	-85	-143	-87
Principal payments on lease financing obligations
887	866	846	810	760	968	1,056	1,016	960	930	904	868	816	790	768	734	687	663	645	614	570	550	534	507	466	448	434	410	372	357	344	324	288	275	264	246	213
Proceeds from issuance of common stock, net
3,191	459	4,602	4,722	3,364	552	1,470	1,753	385,256	476	166,833	76,229	5,267	82	58	103	127	694	271	684	101,979	333	634	1,331	2,927	630	674	1,561	450	561	23,045	86,329	41,283	77	72	166	17,662
Proceeds from issuance of preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	0	0	16,463	0	0	-88	17,750
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-710	-631	-560	-	-	-	-	-	-	-	2,461	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
2,304	-407	3,756	3,912	2,604	-416	414	737	384,296	-454	165,929	75,361	4,451	-	-	-	-	-	-	-	101,409	-	-	-	-	-	-	-	78	-	22,701	68,744	52,458	-3,912	-192	-4,084	-5,970
Effect of exchange rate changes on cash
-14	35	-34	7	-18	41	65	-49	597	-120	-434	1,846	578	-1,623	354	-625	1,600	-725	-1,989	368	449	-35	-864	-708	264	65	971	-658	-377	-30	540	-516	577	-260	-888	1,544	-346
Net increase (decrease) in cash, cash equivalents and restricted cash
-52,846	72,390	-28,949	-527,545	565,704	-347,626	7,446	-14,924	357,304	-119,901	147,975	51,234	-11,183	-10,254	-20,357	-17,547	-16,651	-25,096	-35,421	-24,280	77,772	-25,119	-12,470	-2,474	-18,606	41,175	1,798	42,655	-19,841	-9,683	21,963	55,618	30,561	-20,251	-19,711	-22,268	-30,807